Latest Articles

Publication Date
Safety and efficacy of hormonal therapies used to treat endometriosis in women suffering migraine.

Hormonal therapy is the cornerstone of long-term endometriosis management, especially for women deferring surgery. In patients with comorbid migraine - a common, disabling condition - therapeutic choices must balance efficacy …

Published: Feb. 2, 2026, midnight
Oral diclofenac potassium and intramuscular hyoscine-n-butyl bromide versus oral diclofenac potassium alone for pain relief during hysterosalpingography: a double blind randomized controlled trial.

Hysterosalpingography (HSG) is an important diagnostic tool in infertility, often associated with pain and tubal spasms, potentially resulting in false proximal tubal occlusions. This randomised controlled trial compared oral diclofenac …

Published: Jan. 29, 2026, midnight
Myrrh ameliorates endometriosis by enhancing ER stress-related apoptotic cell death.

Endometriosis is characterized by ectopic growth of endometrial tissue causing severe abdominal pain and inflammation during disease progression. Myrrh, a resin collected from trees of genus Commiphora known for its …

Published: Jan. 29, 2026, midnight
Metabolism-Regulating Microspheres: Design Principles, Therapeutic Applications Across Multisystem Diseases, and Future Perspectives.

Metabolism-regulating microspheres have evolved from conventional drug carriers into active platforms capable of spatiotemporally reprogramming pathological metabolic networks. Chronic diseases are increasingly understood to be driven by metabolic dysregulation, highlighting …

Published: Jan. 27, 2026, midnight
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress The Manila Times

Published: Jan. 23, 2026, 1:20 p.m.
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress manilatimes.net

Published: Jan. 23, 2026, 1:20 p.m.
‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? - Ms. Magazine

‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? Ms. Magazine

Published: Jan. 22, 2026, 12:02 p.m.
New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT - Radiology Business

New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT Radiology Business

Published: Jan. 21, 2026, 10:16 p.m.
‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere - Ms. Magazine

‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere Ms. Magazine

Published: Jan. 21, 2026, 12:05 p.m.
'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science - Ms. Magazine

'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science Ms. Magazine

Published: Jan. 20, 2026, 12:05 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!